0.6114

1.90% 0.0114

After Hours: .60 -0.0114 -1.86%

Vistagen Therapeutics Inc (VTGN)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Vistagen Therapeutics Inc stock is traded at $0.6114, with a volume of 933.85K. It is up +1.90% in the last 24 hours and up +0.68% over the past month. Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Previous Close:

$0.60

Open:

$0.6114

24h Volume:

933.85K

Relative Volume:

1.15

Market Cap:

$24.22M

Revenue:

$1.04M

Net Income/Loss:

$-67.50M

P/E Ratio:

-0.3181

EPS:

-1.9222

Net Cash Flow:

$-60.67M

1W Performance:

+11.12%

1M Performance:

+0.68%

6M Performance:

-84.71%

1Y Performance:

-72.46%

1-Day Range:

$0.59

$0.63

1-Week Range:

$0.53

$0.63

52-Week Range:

$0.43

$5.14

Vistagen Therapeutics Inc Stock (VTGN) Company Profile

Name

Vistagen Therapeutics Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

650-577-3600

Address

343 ALLERTON AVENUE, SOUTH SAN FRANCISCO

Employee

Twitter

@vistagen

Next Earnings Date

2024-11-07

Latest SEC Filings

VTGN's Discussions on Twitter

Compare VTGN vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VTGN Vistagen Therapeutics Inc	0.6114	23.77M	1.04M	-67.50M	-60.67M	-1.9222
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-25	Downgrade	Jefferies	Buy → Hold
Dec-17-25	Downgrade	Maxim Group	Buy → Hold
Dec-17-25	Downgrade	Stifel	Buy → Hold
Dec-17-25	Downgrade	William Blair	Outperform → Mkt Perform
Dec-07-23	Upgrade	Jefferies	Hold → Buy
Aug-07-23	Upgrade	Maxim Group	Hold → Buy
Jul-22-22	Downgrade	Jefferies	Buy → Hold
Jul-22-22	Downgrade	Robert W. Baird	Outperform → Neutral
Jul-22-22	Downgrade	William Blair	Outperform → Mkt Perform
May-20-21	Initiated	Robert W. Baird	Outperform
Feb-18-21	Initiated	Jefferies	Buy
Jan-04-21	Upgrade	William Blair	Mkt Perform → Outperform
Jun-27-18	Initiated	Maxim Group	Buy
Feb-08-18	Reiterated	Chardan Capital Markets	Buy
Mar-28-17	Initiated	Maxim Group	Buy

View All

Vistagen Therapeutics Inc Stock (VTGN) Latest News

Apr 14, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Vistagen Therapeutics, Inc. (VTGN) And Encourages Shareholders to Connect - ACCESS Newswire

Apr 14, 2026

Vistagen Therapeutics, Inc. Files Form 8-K with SEC – Company Information, Address, and Stock Details (April 2026) - Minichart

Apr 14, 2026

Apr 13, 2026

Vistagen Therapeutics grants stock options to executives and employees - Investing.com

Apr 13, 2026

VistaGen Therapeutics Grants Broad Employee Retention Stock Options - TipRanks

Apr 13, 2026

Vistagen awards stock options to CEO Shawn K. Singh and CFO Nick B. Tressler - TradingView — Track All Markets

Apr 13, 2026

[8-K] Vistagen Therapeutics, Inc. Reports Material Event - Stock Titan

Apr 13, 2026

Institution Moves: Will Vistagen Therapeutics Inc outperform during market ralliesPortfolio Growth Summary & AI Forecasted Entry and Exit Points - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

2026-04-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Shareholders to Reach Out | NDAQ:VTGN | Press Release - Stockhouse

Apr 12, 2026

Trading Recap: What is the next catalyst for Vistagen Therapeutics IncInsider Selling & Low Volatility Stock Suggestions - baoquankhu1.vn

Apr 12, 2026

Apr 11, 2026

Vistagen Therapeutics Inc (MEX:VTGN) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Apr 11, 2026

Is Vistagen Therapeutics Inc a potential multi bagger2026 Reactions & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Apr 11, 2026

Hedge Fund Bets: Can Vistagen Therapeutics Inc sustain earnings growthMarket Volume Summary & Daily Profit Maximizing Trade Tips - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Quarterly Risk: Can Vistagen Therapeutics Inc sustain earnings growth2026 Growth vs Value & Weekly Momentum Picks - baoquankhu1.vn

Apr 10, 2026

Vistagen Therapeutics Inc (MEX:VTGN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Apr 10, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vistagen Therapeutics, Inc. (VTGN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 10, 2026

Apr 09, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vistagen Therapeutics, Inc. (VTGN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Apr 08, 2026

Bull Run: Should value investors consider Vistagen Therapeutics Inc2026 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

RSI Check: Why is Vistagen Therapeutics Inc stock going downBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026